课题基金 / 基金详情

Identification of HTLV-1 neutralization epiotpe amino acid sequence its and application

Identification of HTLV-1 neutralization epiotpe amino acid sequence its and application
HTLV-1中和表位氨基酸序列的鉴定及其应用
批准号:
05670284
负责人:
TANAKA Yuetsu
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

TANAKA Yuetsu的其他基金

相似基金

相关文献

中文摘要
翻译
为了确定人t细胞白血病病毒i型(HTLV-I)包膜抗原的中和区,我们从猪和小鼠中获得了许多新的抗包膜gp46单克隆抗体。新单抗识别的表位定位于gp46氨基酸序列186-193,190-195,191-195,191-196和194-199,在合胞体和转化抑制试验中可以中和HTLV-I。卵清蛋白(OVA)偶联的合成gp46肽含有这些中和表位,氨基酸190-199 (pep190-199)和pep180-204,但不含pep185-194或pep194-203,可以在兔体内产生HTLV-I中和抗体反应。然后用5 × 10^7个活的HTLV-I产生物ILT-8M2细胞对这些免疫或非免疫的家兔进行HTLV-I攻击。聚合酶链反应(PCR)结果显示,在未免疫和pep288-312免疫家兔的PBL中检测到HTLV-I原病毒,而在较长时间内,在prp190-199和pep180-204免疫家兔的PBL中未检测到HTLV-I原病毒。这些结果表明,通过合成肽免疫诱导抗gp46中和抗体反应具有保护动物体内免受htlv - 1感染的潜力。
英文摘要
In order to define neutralization regions the envelope antigen of human T-cell leukemia virus type-I (HTLV-I) we have generated a number new antienvelope gp46 mAbs fromrats and mice. Epitopes recognized by new mAbs, which could neutralize HTLV-I in syncytium and transformation inhibition assays, were localized to gp46 amino acid sequences, 186-193,190-195,191-195,191-196 and 194-199. Ovalbumin (OVA) -conjugated synthetic gp46 peptides containing these neutralization epitopes, amino acids 190-199 (pep190-199) and pep180-204, but not pep185-194 or pep194-203, could give rise to HTLV-I neutralizing antibody responses in rabbits. These immune or non-immune rabbits were then challenged with HTLV-I by i. v. inoculation with 5x10^7 live HTLV-I producer ILT-8M2 cells. By a polymerase chain reaction (PCR) assay, it was revealed that HTLV-I provirus was detected in PBL from non-immune and pep288-312-immunized rabbits, whereas the provirus was not detected in PBL from the prp190-199 and pep180-204-immunized rabbits over an extended period. These results suggest that the induction of anti-gp46 neutralizing antibody responses by immunization with synthetic peptides has the potential to protect animals against HTLV-I infection in vivo.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
田中勇悦: "Induction of amtibody response that neutralize human T-cell leukemia virus type I in fection typeI in vitco and in vivo by peptide immunization" Journal of Virology. 68. 6323-6331 (1994)
Yuetsu Tanaka:“通过肽免疫在体外和体内诱导 I 型感染中和人 T 细胞白血病病毒 I 型的抗体反应”,《病毒学杂志》68. 6323-6331 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
田中勇悦ら,他8名: "Induction of antibody response that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization" Journal of Virology. 68. 6323-6331 (1994)
Yuetsu Tanaka 等人和其他 8 人:“通过肽免疫在体外和体内诱导中和人 T 细胞白血病病毒 I 型感染的抗体反应”Journal of Virology 68. 6323-6331 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka, Y etal: "Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization" J,Virol. 68 Oct. 6323-6331 (1994)
Tanaka, Y 等人:“通过肽免疫在体外和体内诱导中和人 T 细胞白血病病毒 I 型感染的抗体反应”J,Virol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Identification of a factor produced by anti-HIV CD4+ T cells induced by dendritic cell-based immunization in the hu-PBL-SCID mice
  • 批准号:
    16017288
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 资助金额:
    $9.6万
  • 财政年份:
    2004
  • 负责人:
    TANAKA Yuetsu
  • 依托单位:
Apoptosis of helper T cells via the costimulatory molecules OX40 stimulated by gp34
  • 批准号:
    14599010
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2002
  • 负责人:
    TANAKA Yuetsu
  • 依托单位:
海外基金